Literature DB >> 21349587

Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study.

Joseph S Goveas1, Mark A Espeland, Patricia Hogan, Vonetta Dotson, Sergey Tarima, Laura H Coker, Judith Ockene, Robert Brunner, Nancy F Woods, Sylvia Wassertheil-Smoller, Jane M Kotchen, Susan Resnick.   

Abstract

OBJECTIVE: Late-life depressive symptoms (DS) increase the risk of incident mild cognitive impairment and probable dementia in the elderly. Our objectives were to examine the relationship between elevated DS and regional brain volumes including frontal lobe subregions, hippocampus and amygdala, and to determine whether elevated DS were associated with increased subclinical cerebrovascular disease in postmenopausal women.
METHODS: DS were assessed an average of 8years prior to structural brain MRI in 1372 women. The 8-item Burnam regression algorithm was used to define DS with a cut-point of 0.009. Adjusting for potential confounders, mean differences in total brain, frontal lobe subregions, hippocampus and amygdala volumes and total ischemic lesion volumes in the basal ganglia and the cerebral white and gray matter outside the basal ganglia were compared between women with and without DS.
RESULTS: Depressed women had lower baseline global cognition and were more likely to have prior hormone therapy history. After full adjustment, DS at baseline were associated with smaller superior and middle frontal gyral volumes. Hippocampal and amygdala volumes, and ischemic lesion volumes were similar in depressed and non-depressed women. LIMITATIONS: Depression was not assessed based on semi-structured interview, and MRI scans were obtained cross-sectionally rather than longitudinally. Longitudinal MRI assessments will be necessary to define the temporal relationships between DS and frontal lobe volumes.
CONCLUSIONS: Elevated DS were associated with lower volumes in certain frontal lobe subregions but not in the medial temporal lobe structures. Our findings support the role of frontal lobe structures in late-life DS among women.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21349587      PMCID: PMC3109161          DOI: 10.1016/j.jad.2011.01.020

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  61 in total

1.  HAMMER: hierarchical attribute matching mechanism for elastic registration.

Authors:  Dinggang Shen; Christos Davatzikos
Journal:  IEEE Trans Med Imaging       Date:  2002-11       Impact factor: 10.048

2.  Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

Authors:  I Driscoll; C Davatzikos; Y An; X Wu; D Shen; M Kraut; S M Resnick
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

3.  Hippocampal volume and incident dementia in geriatric depression.

Authors:  David C Steffens; Martha E Payne; Daniel L Greenberg; Christopher E Byrum; Kathleen A Welsh-Bohmer; H Ryan Wagner; James R MacFall
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

4.  Hippocampal volume in geriatric depression.

Authors:  D C Steffens; C E Byrum; D R McQuoid; D L Greenberg; M E Payne; T F Blitchington; J R MacFall; K R Krishnan
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

Review 5.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

6.  Depressive symptoms, cognitive decline, and risk of AD in older persons.

Authors:  Robert S Wilson; L L Barnes; C F Mendes de Leon; N T Aggarwal; J S Schneider; J Bach; J Pilat; L A Beckett; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

7.  Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.

Authors:  L H Coker; P E Hogan; N R Bryan; L H Kuller; K L Margolis; K Bettermann; R B Wallace; Z Lao; R Freeman; M L Stefanick; S A Shumaker
Journal:  Neurology       Date:  2009-01-13       Impact factor: 9.910

8.  Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.

Authors:  S M Resnick; M A Espeland; S A Jaramillo; C Hirsch; M L Stefanick; A M Murray; J Ockene; C Davatzikos
Journal:  Neurology       Date:  2009-01-13       Impact factor: 9.910

9.  Longitudinal increase in the volume of white matter hyperintensities in late-onset depression.

Authors:  Robert D Nebes; Charles F Reynolds; Fernando Boada; Carolyn C Meltzer; Melanie B Fukui; Judith Saxton; Edythe M Halligan; Steven T DeKosky
Journal:  Int J Geriatr Psychiatry       Date:  2002-06       Impact factor: 3.485

10.  Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration.

Authors:  Sandra Bell-McGinty; Meryl A Butters; Carolyn Cidis Meltzer; Phil J Greer; Charles F Reynolds; James T Becker
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  23 in total

1.  Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia.

Authors:  Mirjam I Geerlings; Adam M Brickman; Nicole Schupf; Davangere P Devanand; José A Luchsinger; Richard Mayeux; Scott A Small
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study.

Authors:  M I Geerlings; S Sigurdsson; G Eiriksdottir; M E Garcia; T B Harris; T Sigurdsson; V Gudnason; L J Launer
Journal:  Psychol Med       Date:  2012-05-30       Impact factor: 7.723

3.  Extreme deep white matter hyperintensity volumes are associated with African American race.

Authors:  Paul A Nyquist; Murat S Bilgel; Rebecca Gottesman; Lisa R Yanek; Taryn F Moy; Lewis C Becker; Jennifer Cuzzocreo; Jerry Prince; David M Yousem; Diane M Becker; Brian G Kral; Dhananjay Vaidya
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

4.  The default mode network may be the key substrate of depressive symptom-related cognitive changes.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Alzheimers Dement       Date:  2012-11-13       Impact factor: 21.566

Review 6.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

7.  Treatment course with antidepressant therapy in late-life depression.

Authors:  Yvette I Sheline; Brianne M Disabato; Jennifer Hranilovich; Carrie Morris; Gina D'Angelo; Carl Pieper; Tommaso Toffanin; Warren D Taylor; James R MacFall; Consuelo Wilkins; Deanna M Barch; Kathleen A Welsh-Bohmer; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

8.  Serum lipid changes following the onset of depressive symptoms in postmenopausal women.

Authors:  Jane E Persons; Jennifer G Robinson; Martha E Payne; Jess G Fiedorowicz
Journal:  Psychiatry Res       Date:  2016-12-05       Impact factor: 3.222

9.  The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study.

Authors:  Chunming Xie; Wenjun Li; Gang Chen; B Douglas Ward; Malgorzata B Franczak; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas
Journal:  Behav Brain Res       Date:  2012-08-14       Impact factor: 3.332

10.  Hippocampal atrophy and subsequent depressive symptoms in older men and women: results from a 10-year prospective cohort.

Authors:  Martine Elbejjani; Rebecca Fuhrer; Michal Abrahamowicz; Bernard Mazoyer; Fabrice Crivello; Christophe Tzourio; Carole Dufouil
Journal:  Am J Epidemiol       Date:  2014-08-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.